Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
5
×
clinical trials
5
×
life sciences
national blog main
national top stories
roche
5
×
san francisco blog main
san francisco top stories
biotech
boston blog main
boston top stories
cancer
national
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
detroit blog main
detroit top stories
indiana blog main
indiana top stories
investing
merck
pfizer
biogen
biotech ipos
bridgebio
cell therapy
deals
What
bio
drug
roundup
cancer
medical
pricing
advanced
advantages
alliance
american
annual
arrival
ash
award
bar
blood
borne
brings
bristol
buy
calls
cancers
changing
color
conference
crispr
data
days
death
decades
dems
despite
diego
expect
family
gamble
gathering
given
growing
guide
Language
unset
Current search:
amgen
×
roche
×
" clinical trials "
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
Bio Roundup: Award Winners, Lung Data, Dems on Drug Pricing & More
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
5 years ago
ASH 2018: A Guide to the Latest for Blood-Borne Cancers and More